{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T05:59:49Z","timestamp":1777528789591,"version":"3.51.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T00:00:00Z","timestamp":1692748800000},"content-version":"vor","delay-in-days":4344,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1007\/s13311-011-0066-9","type":"journal-article","created":{"date-parts":[[2011,9,7]],"date-time":"2011-09-07T20:04:18Z","timestamp":1315425858000},"page":"744-752","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Cell-Based Therapy for Neural Disorders \u2014 Anticipating Challenges"],"prefix":"10.1016","volume":"8","author":[{"given":"Arlene Y.","family":"Chiu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahendra S.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1007\/s13311-011-0066-9_bib1","first-page":"908","article-title":"Experience dictates stem cell fate in the adult hippocampus","volume":"70","author":"Dranovsky","year":"2011","journal-title":"Cell"},{"key":"10.1007\/s13311-011-0066-9_bib2","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.conb.2006.05.011","article-title":"Mechanisms of neural plasticity following brain injury","volume":"16","author":"Wieloch","year":"2006","journal-title":"Curr Opinion in Neurobiology"},{"key":"10.1007\/s13311-011-0066-9_bib3","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1126\/science.1195320","article-title":"Lynx1, a cholinergic brake, limits plasticity in adult visual cortex","volume":"330","author":"Morishita","year":"2010","journal-title":"Science"},{"key":"10.1007\/s13311-011-0066-9_bib4","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1523\/JNEUROSCI.3566-10.2011","article-title":"Multipotent adult progenitor cells prevent macrophage-mediated axonal dieback and promote regrowth after spinal cord injury","volume":"31","author":"Busch","year":"2011","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-011-0066-9_bib5","doi-asserted-by":"crossref","first-page":"9330","DOI":"10.1523\/JNEUROSCI.2488-08.2008","article-title":"Another barrier to regeneration in the CNS: activated macrophages induce extensive retraction of dystrophic axons through direct physical interactions","volume":"28","author":"Horn","year":"2008","journal-title":"J Neurosci"},{"key":"10.1007\/s13311-011-0066-9_bib6","doi-asserted-by":"crossref","first-page":"10343","DOI":"10.1073\/pnas.1105135108","article-title":"Direct conversion of human fibroblasts to dopaminergic neurons","volume":"108","author":"Pfisterer","year":"2011","journal-title":"PNAS USA"},{"key":"10.1007\/s13311-011-0066-9_bib7","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/nature08797","article-title":"Direct conversion of fibroblasts to functional neurons by defined factors","volume":"463","author":"Vierbuchen","year":"2010","journal-title":"Nature"},{"key":"10.1007\/s13311-011-0066-9_bib8","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1602\/neurorx.1.4.382","article-title":"Cell therapy in Parkinson's disease","volume":"1","author":"Lindvall","year":"2004","journal-title":"NeuroRx"},{"key":"10.1007\/s13311-011-0066-9_bib9","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.tips.2009.03.001","article-title":"Prospects of stem cell therapy for replacing doamine neurons in Parkinson's disease","volume":"30","author":"Lindvall","year":"2009","journal-title":"Trends Pharmacol Sci"},{"key":"10.1007\/s13311-011-0066-9_bib10","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.neuron.2011.05.007","article-title":"Translating stem cell studies to the clinic for CNS repair: current state of the art and the need for a","volume":"70","author":"Aboody","year":"2011","journal-title":"Rosetta Stone Neuron"},{"key":"10.1007\/s13311-011-0066-9_bib11","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/nbt0709-606","article-title":"Developing safe therapies from human pluripotent stem cells","volume":"27","author":"Carpenter","year":"2009","journal-title":"Nature Biotech"},{"key":"10.1007\/s13311-011-0066-9_bib12","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.stem.2008.11.012","article-title":"Isolation and production of cells suitable for human therapy: challenges ahead","volume":"4","author":"Ahrlund-Richter","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1007\/s13311-011-0066-9_bib13","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ydbio.2004.08.013","article-title":"Conserved and divergent paths that regulate self-renewal in mouse and human embryonic stem cells","volume":"275","author":"Rao","year":"2004","journal-title":"Developmental Biol"},{"key":"10.1007\/s13311-011-0066-9_bib14","first-page":"467","article-title":"The morphogenesis of evolutionary developmental biology","volume":"47","author":"Gilbert","year":"2003","journal-title":"Int J Dev Biol"},{"key":"10.1007\/s13311-011-0066-9_bib15","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1038\/ng1631","article-title":"Genomic alterations in cultured human embryonic stem cells","volume":"37","author":"Maitra","year":"2005","journal-title":"Nature Genet"},{"key":"10.1007\/s13311-011-0066-9_bib16","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.neuroscience.2006.09.017","article-title":"Human embryonic stem cells: long term stability, absence of senescence and a potential cell source for neural replacement","volume":"145","author":"Zeng","year":"2007","journal-title":"Neuroscience"},{"key":"10.1007\/s13311-011-0066-9_bib17","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nbt788","article-title":"Homologous recombination in human embryonic stem cells","volume":"21","author":"Zwaka","year":"2003","journal-title":"Nature Biotech"},{"key":"10.1007\/s13311-011-0066-9_bib18","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/stem.129","article-title":"A targeted neuroglial reporter line generated by homologous recombination in human embryonic stem cells","volume":"27","author":"Xue","year":"2009","journal-title":"Stem Cells"},{"key":"10.1007\/s13311-011-0066-9_bib19","first-page":"207","article-title":"Controlled genetic modification of stem cells for developing drug discovery tools and novel therapeutic applications","volume":"10","author":"Zeng","year":"2008","journal-title":"Curr Opin Mol Ther"},{"key":"10.1007\/s13311-011-0066-9_bib20","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1091\/mbc.e02-11-0732","article-title":"Consequences of nonadaptive alterations in cancer","volume":"14","author":"Kamb","year":"2003","journal-title":"Mol Biol Cell"},{"key":"10.1007\/s13311-011-0066-9_bib21","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/nature10135","article-title":"Immunogenicity of induced pluripotent stem cells","volume":"474","author":"Zhao","year":"2011","journal-title":"Nature"},{"key":"10.1007\/s13311-011-0066-9_bib22","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1073\/pnas.0812297106","article-title":"Genome-wide association analysis reveals a SOD1 mutation in canine degenerative myelopathy that resembles amyotrophic lateral sclerosis","volume":"106","author":"Awano","year":"2009","journal-title":"PNAS USA"},{"key":"10.1007\/s13311-011-0066-9_bib23","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/jnr.20708","article-title":"Disease progression of human SOD1 (G93A) transgenic ALS model rats","volume":"83","author":"Matsumoto","year":"2006","journal-title":"J Neurosci Res"},{"key":"10.1007\/s13311-011-0066-9_bib24","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1126\/science.8209258","article-title":"Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation","volume":"264","author":"Gurney","year":"1994","journal-title":"Science"},{"key":"10.1007\/s13311-011-0066-9_bib25","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1007\/s12015-010-9192-8","article-title":"Stem cell-based therapeutic applications in retinal degenerative diseases","volume":"7","author":"Huang","year":"2011","journal-title":"Stem Cell Rev"},{"key":"10.1007\/s13311-011-0066-9_bib26","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1002\/stem.513","article-title":"Concise review: stem cells as an emerging platform for antibody therapy of cancer","volume":"28","author":"Frank","year":"2010","journal-title":"Stem Cells"},{"key":"10.1007\/s13311-011-0066-9_bib27","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2174\/157488810791824421","article-title":"Therapeutic targeting of melanoma cells using neural stem cells expressing carboxylesterase, a CPT-11 activating enzyme","volume":"5","author":"Gutova","year":"2010","journal-title":"Curr Stem Cell Res Ther"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-011-0066-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13311-011-0066-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187874792301797X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187874792301797X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-011-0066-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:13:40Z","timestamp":1761808420000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187874792301797X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S187874792301797X"],"URL":"https:\/\/doi.org\/10.1007\/s13311-011-0066-9","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cell-Based Therapy for Neural Disorders \u2014 Anticipating Challenges","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-011-0066-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}